Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumit Madan

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Bioinformatics Advances|April 5, 2023
The Epilepsy Ontology: a community-based ontology tailored for semantic interoperability and text miningAstghik Sargsyan, Philipp Wegner, Stephan Gebel, et al.
Bioinformatics (Oxford, England)|December 21, 2020
The COVID-19 OntologyAstghik Sargsyan, Alpha Tom Kodamullil, Shounak Baksi, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Heliyon|May 18, 2022
Clinical safety and pharmacokinetic evaluation of aqueous extract of <i>Cocculus hirsutus,</i> an anti-viral phytopharmacetical drug as a potential for the treatment of dengue and COVID-19Sajad Khaliq Dar, Sudershan Kumar, Sovan Maiti, et al.
Blood|June 16, 2011
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myelomaSumit Madan, Martha Q Lacy, Angela Dispenzieri, et al.
Nucleic Acids Research|October 11, 2019
SEAweb: the small RNA Expression Atlas web applicationRaza-Ur Rahman, Anna-Maria Liebhoff, Vikas Bansal, et al.
The Lancet. Haematology|September 16, 2021
Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a studyKevin R Kelly, Sikander Ailawadhi, David S Siegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2020
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell LymphomaLeo I Gordon, Jason B Kaplan, Rakesh Popat, et al.
Oncotarget|January 26, 2023
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)Leo I Gordon, Reem Karmali, Jason B Kaplan, et al.
Frontiers in Microbiology|December 16, 2021
<i>Cocculus hirsutus</i>-Derived Phytopharmaceutical Drug Has Potent Anti-dengue ActivityRahul Shukla, Ravi Kant Rajpoot, Ankur Poddar, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Bioinformatics Advances|April 5, 2023
The Epilepsy Ontology: a community-based ontology tailored for semantic interoperability and text miningAstghik Sargsyan, Philipp Wegner, Stephan Gebel, et al.
Bioinformatics (Oxford, England)|December 21, 2020
The COVID-19 OntologyAstghik Sargsyan, Alpha Tom Kodamullil, Shounak Baksi, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Heliyon|May 18, 2022
Clinical safety and pharmacokinetic evaluation of aqueous extract of <i>Cocculus hirsutus,</i> an anti-viral phytopharmacetical drug as a potential for the treatment of dengue and COVID-19Sajad Khaliq Dar, Sudershan Kumar, Sovan Maiti, et al.
Blood|June 16, 2011
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myelomaSumit Madan, Martha Q Lacy, Angela Dispenzieri, et al.
Nucleic Acids Research|October 11, 2019
SEAweb: the small RNA Expression Atlas web applicationRaza-Ur Rahman, Anna-Maria Liebhoff, Vikas Bansal, et al.
The Lancet. Haematology|September 16, 2021
Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a studyKevin R Kelly, Sikander Ailawadhi, David S Siegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2020
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell LymphomaLeo I Gordon, Jason B Kaplan, Rakesh Popat, et al.
Oncotarget|January 26, 2023
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)Leo I Gordon, Reem Karmali, Jason B Kaplan, et al.
Frontiers in Microbiology|December 16, 2021
<i>Cocculus hirsutus</i>-Derived Phytopharmaceutical Drug Has Potent Anti-dengue ActivityRahul Shukla, Ravi Kant Rajpoot, Ankur Poddar, et al.
Pageof 5